医学
多发性硬化
疾病
重症监护医学
精神科
内科学
标识
DOI:10.1056/nejm198301273080409
摘要
No form of treatment has been demonstrated to alter the long-term course of multiple sclerosis. This is not because of lack of effort. From Charcot's time up to the present issue of the Journal,1 , 2 trials of hundreds of various treatments have been reported. A synopsis of the 120 therapeutic claims involving the disease was published last year by the International Federation of Multiple Sclerosis Societies.3 Only one substance, ACTH, has been shown in a controlled double-blind trial to shorten the duration of acute attacks of multiple sclerosis.4 Many physicians believe that steroids are equally effective, but this has not . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI